Brandywine Oak Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$406K Sell
7,050
-232
-3% -$13.3K 0.03% 172
2026
Q1
$442K Sell
7,282
-68
-0.9% -$3.96K 0.04% 160
2025
Q4
$396K Sell
7,350
-934
-11% -$44.9K 0.03% 167
2025
Q3
$374K Hold
8,284
0.03% 174
2025
Q2
$383K Sell
8,284
-142
-2% -$6.97K 0.04% 172
2025
Q1
$514K Hold
8,426
0.05% 144
2024
Q4
$477K Buy
8,426
+889
+12% +$49.7K 0.05% 150
2024
Q3
$390K Hold
7,537
0.04% 174
2024
Q2
$313K Hold
7,537
0.03% 187
2024
Q1
$409K Hold
7,537
0.04% 165
2023
Q4
$387K Sell
7,537
-266
-3% -$14K 0.04% 167
2023
Q3
$453K Hold
7,803
0.05% 150
2023
Q2
$499K Sell
7,803
-1
-0% -$67 0.06% 155
2023
Q1
$541K Hold
7,804
0.06% 152
2022
Q4
$561K Sell
7,804
-68
-0.9% -$5.13K 0.07% 144
2022
Q3
$559K Buy
7,872
+1
+0% +$73 0.08% 142
2022
Q2
$606K Sell
7,871
-625
-7% -$47.6K 0.08% 149
2022
Q1
$620K Buy
8,496
+533
+7% +$35.8K 0.07% 174
2021
Q4
$496K Sell
7,963
-2,154
-21% -$126K 0.05% 199
2021
Q3
$598K Sell
10,117
-375
-4% -$24.7K 0.07% 177
2021
Q2
$701K Buy
10,492
+3,356
+47% +$219K 0.08% 160
2021
Q1
$450K Sell
7,136
-370
-5% -$23K 0.07% 156
2020
Q4
$465K Sell
7,506
-192
-2% -$11.8K 0.07% 151
2020
Q3
$464K Sell
7,698
-404
-5% -$24.3K 0.08% 147
2020
Q2
$476K Sell
8,102
-1,666
-17% -$99.6K 0.08% 137
2020
Q1
$544K Buy
9,768
+2,525
+35% +$154K 0.11% 102
2019
Q4
$464K Sell
7,243
-1,400
-16% -$80.2K 0.08% 124
2019
Q3
$438K Hold
8,643
0.08% 119
2019
Q2
$391K Hold
8,643
0.08% 127
2019
Q1
$412K Hold
8,643
0.09% 117
2018
Q4
$449K Buy
+8,643
New +$464K 0.1% 104

Other funds holding BMY

Brandywine Oak Private Wealth's BMY Position: Q2 2026 in Review

Brandywine Oak Private Wealth reduced its Bristol-Myers Squibb (BMY) stake by 3.2% in Q2 2026, selling an estimated $13.3K and leaving 7,050 shares worth $406K. The position accounts for 0.03% of the portfolio, ranked #172.

Brandywine Oak Private Wealth first reported a position in BMY in Q4 2018 and has held it in 31 quarters since. The position peaked at $701K in Q2 2021. 889 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Brandywine Oak Private Wealth held 7,050 shares of Bristol-Myers Squibb worth $406K as of Q2 2026.
  • Brandywine Oak Private Wealth sold 232 Bristol-Myers Squibb shares in Q2 2026, an estimated $13.3K.
  • Bristol-Myers Squibb made up 0.03% of Brandywine Oak Private Wealth's portfolio in Q2 2026, its #172 holding.
  • Brandywine Oak Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 31 quarters since.
  • Brandywine Oak Private Wealth's Bristol-Myers Squibb position peaked at $701K in Q2 2021.
  • 889 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Brandywine Oak Private Wealth's 13F filing for Q2 2026, filed 16 Jul 2026.